Search Results
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
August, 2024
August 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Jul
Vivek
Dec 29, 2023, 15:35 |
Blog
Vivek Subbiah: Tumor-agnostic therapies advance possibilities for Precision Medicine
Vivek Subbiah shared on LinkedIn: ''Tumor-agnostic therapies advance possibilities for Precision Medicine. Genomics are driving…
Dec 29, 2023, 05:08 |
Blog
Vivek Subbiah: 1 in 3 academic physicians report they are considering leaving their institution within 2 years
Vivek Subbiah shared a post on X/Twitter: ''1 in 3 academic physicians report they are…
Dec 28, 2023, 07:08 |
Blog
Vivek Subbiah: TP53 is an attractive target for novel cancer therapies
Vivek Subbiah shared a post on his X/Twitter page: "Pharmacological reactivation of p53 in the…
Dec 27, 2023, 17:02 |
Blog
Vivek Subbiah: Forward-thinking journal on AI in Oncology and precision medicine
Vivek Subbiah shared on X/Twitter: Just in time for the holidays. Nice to get the…
Dec 27, 2023, 14:02 |
Drugs
Vivek Subbiah: The FDA just finalized the draft guidance for 'RARE DISEASE DRUG DEVELOPMENT'
Vivek Subbiah recently shared on LinkedIn: "Wow! The FDA just finalized the draft guidance for…
Dec 25, 2023, 16:45 |
Insight
Vivek Subbiah: Pleased to share the work of our amazing RET precision medicine team as we review
Vivek Subbiah shared on LinkedIn: "Hot off the press! Pleased to share the work of…
Dec 23, 2023, 15:58 |
Blog
Vivek Subbiah: Here's to four decades of impactful research!
Vivek Subbiah shared on X/Twitter: "Milestone alert! Celebrating Journal of Clinical Oncology's 40th anniversary. Huge…
Dec 23, 2023, 08:10 |
Blog
Vivek Ramaswamy: I stepped down from my job as a biotech CEO
Vivek Ramaswamy, the founder of Roivant Sciences and American presidential candidate, shared on X: "I…
Dec 23, 2023, 04:00 |
Insight
Vivek Subbiah: Such a delight to share our non-human primate publication as a pre-cursor to our First-in-human phase 1 trial
Vivek Subbiah shared on X/Twitter: ''Such a delight to share our non-human primate publication on First-in-cynomolgus…
Dec 20, 2023, 11:26 |
Blog
Vivek Subbiah: Excited to join as a panelist in the upcoming STAT statnews event "Cancer's Breakthrough Engine"
Vivek Subbiah shared a post on LinkedIn: "Save the Date! Excited to join as a…
15
16
17
18
19
All:
301
Posts:
161 - 170
Highlights on the U.S. - India Cancer Moonshot Dialogue
The Nobel Prize: "Without him my kids wouldn’t be here" - cancer survivor Sharon Belvin
The plight of cancer patients in war-torn regions highlight the urgent need for our collective support - UICC
Top 100 Xfluencers in Sarcoma: Key Opinion Leaders to follow on X (Twitter) in 2024
A Manifesto to Improve Cancer Care in Conflict-Affected Areas: The Lancet
Facebook
RSS Feed
Twitter
Linkedin
Youtube